
You can purchase shares of RESVERLOGIX CORP by Resverlogix Corp. (OTCPK:RVXCF) through any online brokerage.
There are no as such competitors for RESVERLOGIX CORP by Resverlogix Corp..
There is no analysis for RESVERLOGIX CORP by Resverlogix Corp. to provide a consensus price target.
The stock price for RESVERLOGIX CORP by Resverlogix Corp. (OTCPK: RVXCF) is $0.06045 last updated October 30, 2026 at 12:11 PM EDT.
There are no upcoming dividends for RESVERLOGIX CORP by Resverlogix Corp..
RESVERLOGIX CORP by Resverlogix Corp. does not have any upcoming earnings scheduled.
There is no upcoming split for RESVERLOGIX CORP by Resverlogix Corp..
RESVERLOGIX CORP by Resverlogix Corp. is in the Health Care sector and Biotechnology industry. They are listed on the OTCPK.
Resverlogix Corp clinical-stage biotechnology company. The company is developing apabetalone (RVX-208), a first-in-class, small molecule that is a selective BET (bromodomain and extra-terminal) inhibitor. BET bromodomain inhibition is an epigenetic...